[1] JIA C F,WANG Z Q,SUN X X,et al. Ascending aortic distensibility and target organ damage in primary hypertension without diabetes[J].Int J Cardiovasc Imaging,2017,33(8):1245-1251.
[2] 付艳娜. 糖尿病肾病患者营养状况及其与血清胱抑素C水平的相关性[J].中国老年学杂志,2018,38(9):2092-2094.
[4] 中国高血压防治指南修订委员会. 中国高血压防治指南2010[J].中国医学前沿杂志(电子版),2011,3(5):42-93.
[5] 李玉明,杨宁. 从防控危险因素角度看2017美国心脏病学会/美国心脏协会高血压指南[J].中华高血压杂志,2017,25(11):1009-1011.
[6] LMA B,RS B,WMA B. Alterations on a key nephrogenic/cardiogenic gene expression linked to hypertension development-science direct[J].Clin Investig Arterioscler,2020,32(2):70-78.
[7] ZHANG D Y,CHENG Y B,GUO Q H,et al. Subtypes of masked hypertension and target organ damage in untreated outpatients[J].Blood Press,2020,29(5):299-307.
[8] 郑莹莹. 糖尿病患者血清胱抑素C、尿RBP水平变化及其与Scr和Ccr的关系[J].山东医药,2019,59(4):58-60.
[9] 段跃兴,林仲秋,董凤英,等. 不同血压评估参数与老年高血压患者靶器官损害的关系[J].山东医药,2017,57(17):53-55.
[10] 程书平,李明,谭诗云. 血清AFP、PIVKA-Ⅱ、GGT、GGT/ALT检测对早期原发性肝癌的诊断价值[J].山东医药,2021,61(1):61-65.
[11] 肖巧环,韩红彦,贾海珍,等. 高血压患者血清γ-谷氨酰转移酶与冠状动脉病变的相关性研究[J].临床心血管病杂志,2018,34(4):366-369.
[12] 罗鹏,夏华松,刘恋,等. 血清γ-谷氨酰转肽酶对高血压无症状性亚临床靶器官损害早期检出的意义[J].临床心血管病杂志,2019,35(5):448-452.
[13] AC A,EB A,SD A,et al. The dark side of gamma-glutamyltransferase(GGT):Pathogenic effects of an antioxidant enzyme[J].Free Radic Biol Med,2020,160(14):807-819.